SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Feb-24 8:09 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-24 | Grant | 3,320 | -- | -- | 4% 93.55K to 96.87K | |
14-Feb-24 8:09 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-24 | Payment of Exercise | 973 | $12.41 | $12,074.90 | (1%) 96.87K to 95.9K | |
06-Dec-23 8:19 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 05-Dec-23 | Sale | 2,412 | $9.63 | $23,227.60 | (3%) 95.96K to 93.55K | |
05-Dec-23 9:11 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-23 | Payment of Exercise | 1,595 | $9.49 | $15,136.50 | (2%) 97.56K to 95.96K | |
17-Mar-23 6:41 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Mar-23 | Option Exercise | 10,440 | $14.00 | $146,160.00 | 11% 97.56K to 108.0K | |
17-Mar-23 6:41 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Mar-23 | Planned Option Sale | 10,440 | $44.43 | $463,802.00 | (10%) 108.0K to 97.56K | |
15-Feb-23 9:44 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-23 | Grant | 20,997 | -- | -- | 25% 83.46K to 104.46K | |
15-Feb-23 9:44 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-23 | Payment of Exercise | 6,904 | $52.77 | $364,324.00 | (7%) 104.46K to 97.56K | |
13-Feb-23 7:58 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 09-Feb-23 | Sale (Planned) | 5,000 | $53.76 | $268,816.00 | (6%) 88.46K to 83.46K | |
10-Jan-23 7:11 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 09-Jan-23 | Option Exercise | 2,812 | $14.18 | $39,874.20 | 3% 85.65K to 88.46K | |
19-Dec-22 7:53 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 19-Dec-22 | Option Exercise | 4,148 | $14.18 | $58,818.60 | 5% 81.5K to 85.65K | |
05-Dec-22 7:20 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-22 | Payment of Exercise | 1,055 | $44.33 | $46,768.20 | (1%) 82.56K to 81.5K | |
28-Nov-22 6:20 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 23-Nov-22 | Grant | 21,000 | -- | -- | 34% 61.56K to 82.56K | |
21-Jun-22 4:01 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 17-Jun-22 | Option Exercise | 3,480 | $11.77 | $40,959.60 | 6% 58.08K to 61.56K | |
15-Feb-22 9:36 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 14-Feb-22 | Grant | 3,034 | -- | -- | 5% 56.0K to 59.04K | |
15-Feb-22 9:36 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 14-Feb-22 | Payment of Exercise | 958 | $62.49 | $59,865.40 | (2%) 59.04K to 58.08K | |
03-Dec-21 6:38 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-21 | Payment of Exercise | 557 | $87.68 | $48,837.80 | (< 1%) 56.56K to 56.0K | 4% |
23-Nov-21 7:31 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 19-Nov-21 | Grant | 6,800 | -- | -- | 14% 49.76K to 56.56K | |
08-Jan-21 8:57 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 08-Jan-21 | Market Sale (Planned) | 6,000 | $45.58 | $273,463.00 | (9%) 67.76K to 61.76K | (< 1%) |
16-Dec-20 6:43 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Dec-20 | Payment of Exercise | 770 | $42.52 | $32,740.40 | (1%) 56.53K to 55.76K | < 1% |
16-Dec-20 6:43 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Dec-20 | Option Exercise | 2,625 | -- | -- | 5% 53.9K to 56.53K | |
20-Nov-20 8:25 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 20-Nov-20 | Grant | 7,600 | -- | -- | 16% 46.3K to 53.9K | |
12-Nov-20 4:12 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Nov-20 | Option Exercise | 3,480 | $2.54 | $8,849.29 | 8% 42.82K to 46.3K | |
07-May-20 5:35 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 05-May-20 | Option Exercise | 1,740 | $1.21 | $2,099.83 | 4% 41.08K to 42.82K | |
18-Feb-20 6:04 AM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-20 | Grant | 1,575 | -- | -- | 4% 40.05K to 41.63K | |
18-Feb-20 6:04 AM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-20 | Payment of Exercise | 545 | $52.76 | $28,754.20 | (1%) 41.63K to 41.08K | 20% |
06-Jan-20 6:17 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 02-Jan-20 | Market Option Sale (Planned) | 2,625 | $60.88 | $159,810.00 | (5%) 50.05K to 47.43K | 31% |
06-Jan-20 6:17 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 02-Jan-20 | Market Sale (Planned) | 7,375 | $60.88 | $448,990.00 | (16%) 47.43K to 40.05K | 31% |
06-Jan-20 6:17 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 16-Dec-19 | Payment of Exercise | 1,165 | $63.88 | $74,420.20 | (2%) 51.22K to 50.05K | 34% |
06-Jan-20 6:17 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 16-Dec-19 | Option Exercise | 2,625 | -- | -- | 5% 48.59K to 51.22K | |
25-Feb-19 4:18 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-19 | Option Exercise | 6,960 | $1.51 | $10,499.20 | 8% 90.23K to 97.19K | |
13-Feb-19 9:21 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-19 | Grant | 14,700 | -- | -- | 18% 80.42K to 95.12K | |
13-Feb-19 9:21 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-19 | Payment of Exercise | 4,890 | $88.88 | $434,623.00 | (5%) 95.12K to 90.23K | 52% |
20-Jun-18 4:22 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 18-Jun-18 | Option Exercise | 6,960 | $1.98 | $13,798.90 | 9% 73.46K to 80.42K | |
12-Jun-18 5:32 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Jun-18 | Market Sale (Planned) | 15,000 | $120.57 | $1,808,520.00 | (17%) 88.46K to 73.46K | 65% |
20-Mar-18 6:39 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 19-Mar-18 | Market Sale (Planned) | 9,000 | $86.48 | $778,331.00 | (9%) 97.46K to 88.46K | 51% |
13-Feb-18 6:27 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-18 | Grant | 7,846 | -- | -- | 9% 91.98K to 99.83K | |
13-Feb-18 6:27 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-18 | Payment of Exercise | 2,367 | $76.85 | $181,892.00 | (2%) 99.83K to 97.46K | 45% |
12-Apr-17 4:13 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Apr-17 | Option Exercise | 29,274 | $2.97 | $87,058.00 | 47% 62.7K to 91.98K | |
15-Feb-17 5:44 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-17 | Grant | 2,600 | -- | -- | 4% 61.09K to 63.69K | |
15-Feb-17 5:44 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-17 | Payment of Exercise | 981 | $29.82 | $29,248.50 | (2%) 63.69K to 62.7K | (42%) |
29-Feb-16 4:23 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 26-Feb-16 | Option Exercise | 6,689 | $1.29 | $8,648.88 | 11% 60.4K to 67.09K | |
25-Nov-15 5:49 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 24-Nov-15 | Market Sale (Planned) | 6,000 | $30.15 | $180,922.00 | (10%) 60.4K to 54.4K | (30%) |
16-Oct-15 4:05 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Oct-15 | Market Sale (Planned) | 7,500 | $40.10 | $300,742.00 | (11%) 67.9K to 60.4K | 2% |
10-Sep-15 5:17 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 08-Sep-15 | Market Sale (Planned) | 7,500 | $39.55 | $296,653.00 | (10%) 75.4K to 67.9K | < 1% |
10-Aug-15 4:31 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 07-Aug-15 | Market Sale (Planned) | 7,500 | $42.85 | $321,389.00 | (9%) 82.9K to 75.4K | 8% |
14-Jul-15 4:19 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Jul-15 | Market Sale (Planned) | 7,500 | $46.29 | $347,207.00 | (8%) 90.4K to 82.9K | 15% |
12-Jun-15 5:09 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Jun-15 | Market Sale (Planned) | 7,500 | $42.51 | $318,812.00 | (8%) 97.9K to 90.4K | 8% |
20-May-15 4:16 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 19-May-15 | Market Sale (Planned) | 24,000 | $40.13 | $963,094.00 | (20%) 121.9K to 97.9K | 2% |
20-Jan-15 4:03 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 16-Jan-15 | Market Sale (Planned) | 4,500 | $49.45 | $222,505.00 | (4%) 126.4K to 121.9K | 21% |